Pfizer, Moderna mRNA vaccines are effective even without post-shot symptoms or prior infection, Johns Hopkins study finds When the two messenger RNA vaccines for COVID-19 first became readily available, many people were talking about side effects—everything from headaches to chills to feeling exhausted for a couple days. Yet plenty of […]
Moderna Inc.’s Covid vaccine generated more than double the antibodies of a similar shot made by Pfizer Inc. and BioNTech SE in research that compared immune responses evoked by the two inoculations. The study is one of the first to compare levels of antibodies produced by the two vaccines, which are thought to be […]
Moderna says neutralizing antibodies generated by its COVID-19 vaccine against three variants of the virus that causes the disease waned substantially 6 months after the second dose. Because of this, the company expects an increase in breakthrough infections with a need for boosters before winter. In an experiment, a 50-milligram […]
La farmacéutica Moderna ha publicado datos sobre la vacuna Spikevax frente a la COVID-19. Destaca la eficacia de la vacuna del 93% en el análisis final, permaneciendo hasta los seis meses desde la recepción de la segunda dosis. Además, en un ensayo fase II la vacunación con dosis de 50 microgramos de […]
Un artículo aun no revisado por pares expone los resultados de la respuesta inmune a la vacuna Spikevax de la farmacéutica Moderna a una concentración de 25 microgramos en lugar de los 100 microgramos de la actualmente comercializada. Analizan las respuestas de anticuerpos de unión, los neutralizantes, las células específicas T CD4+ […]
Pfizer, Moderna vaccines effective against Indian variants: study. The lab-based study was carried out by the NYU Grossman School of Medicine and NYU Langone Center and is preliminary because it has not yet been published in a peer-reviewed journal. Full story: http://u.afp.com/UeMB
Redacción Médica analiza las disimilitudes entre la eficacia, el tiempo de protección o su conservación, entre otros Estados Unidos ya ha aprobado la vacuna de Janssen contra el Covid-19 para su uso de emergencia. La compañía farmacéutica suministrará hasta 200 millones de dosis a la Unión Europea a lo largo de 2021. Hasta […]
Vaccination with the Pfizer or Moderna vaccine reduces infections by 90%, while a single dose confers 80% protection, shows a study led by the US Centers for Disease Control and Prevention (CDC) that followed essential workers through the worst months of the pandemic. The study is one of a small […]
